Full Text

Turn on search term navigation

© 2021 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.

Abstract

The fruit of Schisandra chinensis, Omija, is a well-known traditional medicine used as an anti-tussive and anti-diarrhea agent, with various biological activities derived from the dibenzocyclooctadiene-type lignans. A high-pressure liquid chromatography-diode array detector (HPLC-DAD) method was used to determine seven lignans (schisandrol A and B, tigloylgomisin H, angeloylgomisin H, schisandrin A, B, and C) in the different plant parts and beverages of the fruit of S. chinensis grown in Korea. The contents of these lignans in the plant parts descended in the following order: seeds, flowers, leaves, pulp, and stems. The total lignan content in Omija beverages fermented with white sugar for 12 months increased by 2.6-fold. Omija was fermented for 12 months with white sugar, brown sugar, and oligosaccharide/white sugar (1:1, w/w). The total lignan content in Omija fermented with oligosaccharide/white sugar was approximately 1.2- and 1.7-fold higher than those fermented with white sugar and brown sugar, respectively. A drink prepared by immersion of the fruit in alcohol had a higher total lignan content than these fermented beverages. This is the first report documenting the quantitative changes in dibenzocyclooctadiene-type lignans over a fermentation period and the effects of the fermentable sugars on this eco-friendly fermentation process.

Details

Title
Dibenzocyclooctadiene Lignans in Plant Parts and Fermented Beverages of Schisandra chinensis
Author
Woo Sung Park 1   VIAFID ORCID Logo  ; Kyung Ah Koo 1   VIAFID ORCID Logo  ; Ji-Yeong Bae 2   VIAFID ORCID Logo  ; Hye-Jin, Kim 1   VIAFID ORCID Logo  ; Dong-Min, Kang 1 ; Ji-Min, Kwon 1 ; Seung-Mann Paek 1 ; Lee, Mi Kyeong 3 ; Chul Young Kim 4   VIAFID ORCID Logo  ; Mi-Jeong Ahn 1 

 College of Pharmacy and Research Institute of Pharmaceutical Sciences, Gyeongsang National University, Jinju 52828, Korea; [email protected] (W.S.P.); [email protected] (K.A.K.); [email protected] (H.-J.K.); [email protected] (D.-M.K.); [email protected] (J.-M.K.); [email protected] (S.-M.P.) 
 College of Pharmacy, Jeju National University, Jeju 63243, Korea; [email protected]; Interdisciplinary Graduate Program in Advanced Convergence Technology & Science, Jeju National University, Jeju 63243, Korea 
 College of Pharmacy, Chungbuk National University, Cheongju 28160, Korea; [email protected] 
 College of Pharmacy, Institute of Pharmaceutical Science and Technology, Hanyang University, Ansan 15588, Korea 
First page
361
Publication year
2021
Publication date
2021
Publisher
MDPI AG
e-ISSN
22237747
Source type
Scholarly Journal
Language of publication
English
ProQuest document ID
2599093274
Copyright
© 2021 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.